58 related articles for article (PubMed ID: 38566150)
21. Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.
Rizzo A; Cusmai A; Giovannelli F; Acquafredda S; Rinaldi L; Misino A; Montagna ES; Ungaro V; Lorusso M; Palmiotti G
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326555
[TBL] [Abstract][Full Text] [Related]
22. Management of Ground-Glass Nodules: When and How to Operate?
Kim YT
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158981
[TBL] [Abstract][Full Text] [Related]
23. The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.
Santoni M; Rizzo A; Mollica V; Matrana MR; Rosellini M; Faloppi L; Marchetti A; Battelli N; Massari F
Crit Rev Oncol Hematol; 2022 Feb; 170():103596. PubMed ID: 35031442
[TBL] [Abstract][Full Text] [Related]
24. Benign and malignant pulmonary part-solid nodules: differentiation via thin-section computed tomography.
Li WJ; Lv FJ; Tan YW; Fu BJ; Chu ZG
Quant Imaging Med Surg; 2022 Jan; 12(1):699-710. PubMed ID: 34993112
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Invasive Adenocarcinomas among Pure Ground-Glass Nodules Less Than 2 cm in Diameter.
Hsu WC; Huang PC; Pan KT; Chuang WY; Wu CY; Wong HF; Yang CT; Wan YL
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439100
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of resected solitary ground-glass opacities: Comparison between benign and malignant nodules.
Qin Y; Xu Y; Ma D; Tian Z; Huang C; Zhou X; He J; Liu L; Guo C; Wang G; Zhang J; Wang Y; Liu H
Thorac Cancer; 2020 Oct; 11(10):2767-2774. PubMed ID: 32844603
[TBL] [Abstract][Full Text] [Related]
27. CT Characteristics for Predicting Invasiveness in Pulmonary Pure Ground-Glass Nodules.
Chu ZG; Li WJ; Fu BJ; Lv FJ
AJR Am J Roentgenol; 2020 Aug; 215(2):351-358. PubMed ID: 32348187
[No Abstract] [Full Text] [Related]
28. Analysis of CT morphologic features and attenuation for differentiating among transient lesions, atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive and invasive adenocarcinoma presenting as pure ground-glass nodules.
Qi L; Xue K; Li C; He W; Mao D; Xiao L; Hua Y; Li M
Sci Rep; 2019 Oct; 9(1):14586. PubMed ID: 31601919
[TBL] [Abstract][Full Text] [Related]
29. Peripheral vessel and air bronchograms for detecting the pathologic patterns of subsolid nodules.
Zhang C; Li J; Sun M; Li S; Li J; Li Q; Zhu Z
Clin Imaging; 2019; 56():63-68. PubMed ID: 30933847
[TBL] [Abstract][Full Text] [Related]
30. Can CT imaging features of ground-glass opacity predict invasiveness? A meta-analysis.
Dai J; Yu G; Yu J
Thorac Cancer; 2018 Apr; 9(4):452-458. PubMed ID: 29446528
[TBL] [Abstract][Full Text] [Related]
31. High-resolution Computed Tomography Features Distinguishing Benign and Malignant Lesions Manifesting as Persistent Solitary Subsolid Nodules.
Yang W; Sun Y; Fang W; Qian F; Ye J; Chen Q; Jiang Y; Yu K; Han B
Clin Lung Cancer; 2018 Jan; 19(1):e75-e83. PubMed ID: 28822623
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology.
Gao JW; Rizzo S; Ma LH; Qiu XY; Warth A; Seki N; Hasegawa M; Zou JW; Li Q; Femia M; Lv TF; Song Y;
Transl Lung Cancer Res; 2017 Feb; 6(1):68-75. PubMed ID: 28331826
[TBL] [Abstract][Full Text] [Related]
33. Clinical, pathological, and radiological characteristics of solitary ground-glass opacity lung nodules on high-resolution computed tomography.
Qiu ZX; Cheng Y; Liu D; Wang WY; Wu X; Wu WL; Li WM
Ther Clin Risk Manag; 2016; 12():1445-1453. PubMed ID: 27703366
[TBL] [Abstract][Full Text] [Related]
34. Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign.
Hu H; Wang Q; Tang H; Xiong L; Lin Q
Thorac Cancer; 2016 Jan; 7(1):80-7. PubMed ID: 26913083
[TBL] [Abstract][Full Text] [Related]
35. Differentiating pre- and minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in Caucasian patients.
Cohen JG; Reymond E; Lederlin M; Medici M; Lantuejoul S; Laurent F; Arbib F; Jankowski A; Moreau-Gaudry A; Ferretti GR
Eur J Radiol; 2015 Apr; 84(4):738-44. PubMed ID: 25623825
[TBL] [Abstract][Full Text] [Related]
36. Results of the two incidence screenings in the National Lung Screening Trial.
Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
[TBL] [Abstract][Full Text] [Related]
37. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.
Humphrey LL; Deffebach M; Pappas M; Baumann C; Artis K; Mitchell JP; Zakher B; Fu R; Slatore CG
Ann Intern Med; 2013 Sep; 159(6):411-420. PubMed ID: 23897166
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
[TBL] [Abstract][Full Text] [Related]
39. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features.
Lee SM; Park CM; Goo JM; Lee HJ; Wi JY; Kang CH
Radiology; 2013 Jul; 268(1):265-73. PubMed ID: 23468575
[TBL] [Abstract][Full Text] [Related]
40. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
Aberle DR; Abtin F; Brown K
J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
